NYR-BI03 

N/A

Report date: 2026/04/25 20:00:23
NMEFirst In Class

Base Information

Drug NameNYR-BI03 
Drug Alias NameXolatrypNYR-BI03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential channels inhibitors
TargetsTransient receptor potential channels
Therapy Area/IndicationsReperfusion InjuryMyocardial InfarctionBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNyrada Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNyrada Pty Ltd
Inactive CompaniesN/A
Active IndicationsReperfusion InjuryMyocardial InfarctionBrain Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A